- Home
- NVNI vs PRTG Comparison
NVNI vs PRTG Comparison
Compare NVNI & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- PRTG
- Stock Information
- Founded
- NVNI 2019
- PRTG 1973
- Country
- NVNI Brazil
- PRTG British Virgin Islands
- Employees
- NVNI N/A
- PRTG N/A
- Industry
- NVNI
- PRTG Oil & Gas Production
- Sector
- NVNI
- PRTG Energy
- Exchange
- NVNI Nasdaq
- PRTG Nasdaq
- Market Cap
- NVNI 10.4M
- PRTG 11.1M
- IPO Year
- NVNI N/A
- PRTG N/A
- Fundamental
- Price
- NVNI $0.16
- PRTG $8.45
- Analyst Decision
- NVNI
- PRTG
- Analyst Count
- NVNI 0
- PRTG 0
- Target Price
- NVNI N/A
- PRTG N/A
- AVG Volume (30 Days)
- NVNI 3.6M
- PRTG 3.6M
- Earning Date
- NVNI 05-07-2025
- PRTG 05-06-2025
- Dividend Yield
- NVNI N/A
- PRTG N/A
- EPS Growth
- NVNI N/A
- PRTG N/A
- EPS
- NVNI N/A
- PRTG N/A
- Revenue
- NVNI $23,558,620.00
- PRTG N/A
- Revenue This Year
- NVNI $25.91
- PRTG N/A
- Revenue Next Year
- NVNI $21.68
- PRTG N/A
- P/E Ratio
- NVNI N/A
- PRTG N/A
- Revenue Growth
- NVNI 38.59
- PRTG N/A
- 52 Week Low
- NVNI $0.16
- PRTG $2.10
- 52 Week High
- NVNI $12.19
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- NVNI 30.09
- PRTG 56.90
- Support Level
- NVNI $0.16
- PRTG $6.75
- Resistance Level
- NVNI $0.17
- PRTG $15.82
- Average True Range (ATR)
- NVNI 0.02
- PRTG 2.26
- MACD
- NVNI 0.06
- PRTG 0.15
- Stochastic Oscillator
- NVNI 30.49
- PRTG 34.46
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.